Statement Of Cash Flows [Abstract]

Medicover - Filing #679261

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
EUR
184,000,000 EUR
176,000,000 EUR
EUR
8,000,000 EUR
176,000,000 EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
137,000,000 EUR
118,000,000 EUR
19,000,000 EUR
EUR
118,000,000 EUR
EUR
EUR
EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in inventories
51,000,000 EUR
127,000,000 EUR
Adjustments for unrealised foreign exchange losses (gains)
65,000,000 EUR
39,000,000 EUR
Adjustments for share-based payments
94,000,000 EUR
96,000,000 EUR
Other adjustments for non-cash items
77,000,000 EUR
22,000,000 EUR
Income taxes paid (refund), classified as operating activities
288,000,000 EUR
191,000,000 EUR
Cash flows from (used in) operating activities
2,050,000,000 EUR
1,702,000,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from losing control of subsidiaries or other businesses, classified as investing activities
140,000,000 EUR
EUR
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
196,000,000 EUR
2,291,000,000 EUR
Cash advances and loans made to other parties, classified as investing activities
76,000,000 EUR
0 EUR
Cash receipts from repayment of advances and loans made to other parties, classified as investing activities
1,000,000 EUR
EUR
Interest received, classified as investing activities
39,000,000 EUR
17,000,000 EUR
Other inflows (outflows) of cash, classified as investing activities
194,000,000 EUR
1,864,000,000 EUR
Cash flows from (used in) investing activities
1,198,000,000 EUR
1,848,000,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments from changes in ownership interests in subsidiaries that do not result in loss of control
46,000,000 EUR
77,000,000 EUR
Proceeds from issuing shares
3,000,000 EUR
EUR
Payments to acquire or redeem entity's shares
3,000,000 EUR
EUR
Proceeds from borrowings, classified as financing activities
4,619,000,000 EUR
5,241,000,000 EUR
Repayments of borrowings, classified as financing activities
3,973,000,000 EUR
4,347,000,000 EUR
Payments of lease liabilities, classified as financing activities
655,000,000 EUR
506,000,000 EUR
Dividends paid, classified as financing activities
179,000,000 EUR
178,000,000 EUR
Interest paid, classified as financing activities
465,000,000 EUR
324,000,000 EUR
Cash flows from (used in) financing activities
737,000,000 EUR
243,000,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
115,000,000 EUR
389,000,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
11,000,000 EUR
26,000,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
115,000,000 EUR
389,000,000 EUR
Cash and cash equivalents
508,000,000 EUR
404,000,000 EUR
819,000,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.